Estimation of seasonal influenza disease burden using sentinel site data in Pakistan 2017-2019: A cross-sectional study.
Pakistan
disease burden
influenza
Journal
Influenza and other respiratory viruses
ISSN: 1750-2659
Titre abrégé: Influenza Other Respir Viruses
Pays: England
ID NLM: 101304007
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
received:
02
02
2023
revised:
25
02
2023
accepted:
28
02
2023
medline:
28
3
2023
entrez:
27
3
2023
pubmed:
28
3
2023
Statut:
epublish
Résumé
The influenza A(H1N1)pdm09 pandemic highlighted the need for reliable disease burden estimation from low- and middle-income countries like Pakistan. We designed retrospective age-stratified estimation of influenza-related severe acute respiratory infections (SARIs) incidence in Islamabad Pakistan 2017-2019. The catchment area was mapped on SARI data from one designated influenza sentinel site and other healthcare facilities in the Islamabad region. The incidence rate was calculated as per 100,000 for each age group with 95% confidence interval. The catchment population for the sentinel site was 0.7 million against the total denominator of 1.015 million, and incidence rates were adjusted. During January 2017 to December 2019, among 13,905 hospitalizations, 6715 (48%) patients were enrolled; 1208 of these (18%) were positive for influenza. During 2017, influenza A/H3 dominated with 52% detections followed by A(H1N1)pdm09 (35%) and influenza B (13%). Furthermore, elderly 65+ years age group had highest hospitalizations and influenza positive. The incidence rates of all cause respiratory and influenza-related SARI were highest among children >5 years; highest incidence was found in 0 to 11 month/year group with 424/100,000 cases and lowest in 5-15 years 56/100,000. The estimated average annual influenza-associated hospitalization percentage was 29.3% during the study period. Influenza accounts for a significant proportion of respiratory morbidity and hospitalization. These estimates would enable governments for evidence-based decisions and priority allocation of health resources. It is necessary to test for other respiratory pathogens for more clear disease burden estimation.
Sections du résumé
Background
The influenza A(H1N1)pdm09 pandemic highlighted the need for reliable disease burden estimation from low- and middle-income countries like Pakistan. We designed retrospective age-stratified estimation of influenza-related severe acute respiratory infections (SARIs) incidence in Islamabad Pakistan 2017-2019.
Materials and Methods
The catchment area was mapped on SARI data from one designated influenza sentinel site and other healthcare facilities in the Islamabad region. The incidence rate was calculated as per 100,000 for each age group with 95% confidence interval.
Results
The catchment population for the sentinel site was 0.7 million against the total denominator of 1.015 million, and incidence rates were adjusted. During January 2017 to December 2019, among 13,905 hospitalizations, 6715 (48%) patients were enrolled; 1208 of these (18%) were positive for influenza. During 2017, influenza A/H3 dominated with 52% detections followed by A(H1N1)pdm09 (35%) and influenza B (13%). Furthermore, elderly 65+ years age group had highest hospitalizations and influenza positive. The incidence rates of all cause respiratory and influenza-related SARI were highest among children >5 years; highest incidence was found in 0 to 11 month/year group with 424/100,000 cases and lowest in 5-15 years 56/100,000. The estimated average annual influenza-associated hospitalization percentage was 29.3% during the study period.
Conclusion
Influenza accounts for a significant proportion of respiratory morbidity and hospitalization. These estimates would enable governments for evidence-based decisions and priority allocation of health resources. It is necessary to test for other respiratory pathogens for more clear disease burden estimation.
Identifiants
pubmed: 36970573
doi: 10.1111/irv.13125
pii: IRV13125
pmc: PMC10030357
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e13125Informations de copyright
© 2023 The Authors. Influenza and Other Respiratory Viruses published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
There is conflict of interest of author and any coauthor of this article.
Références
PLoS One. 2022 Dec 13;17(12):e0278900
pubmed: 36512615
Influenza Other Respir Viruses. 2018 Jan;12(1):146-152
pubmed: 29205882
J Med Virol. 2020 Apr 21;:
pubmed: 32314812
East Mediterr Health J. 2016 Oct 02;22(7):460-467
pubmed: 27714740
PLoS One. 2015 May 04;10(5):e0124122
pubmed: 25938466
Influenza Other Respir Viruses. 2022 Jul;16(4):740-748
pubmed: 35289078
J Infect. 2015 Feb;70(2):160-70
pubmed: 25218056
Emerg Infect Dis. 2021 Oct;27(10):2648-2657
pubmed: 34545793
PLoS Med. 2021 Mar 1;18(3):e1003550
pubmed: 33647033
Sci Rep. 2021 Feb 3;11(1):2886
pubmed: 33536462
Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
East Mediterr Health J. 2016 Oct 02;22(7):432-439
pubmed: 27714736
Oman Med J. 2017 Sep;32(5):359-364
pubmed: 29026466
PLoS Med. 2006 Apr;3(4):e89
pubmed: 16509764
Hum Vaccin Immunother. 2018 Apr 3;14(4):952-957
pubmed: 29333939